Burkitt lymphoma - Subtypes, pathogenesis, and treatment strategies Meeting Abstract


Author: Noy, A.
Abstract Title: Burkitt lymphoma - Subtypes, pathogenesis, and treatment strategies
Meeting Title: 8th Annual Meeting of the Society of Hematologic Oncology (SOHO)
Abstract: Burkitt's lymphoma (BL) is a rare and highly aggressive Non-Hodgkin lymphoma (NHL) with a germinal center phenotype, a nearly universal myc oncogene translocation to an enhancer element and a proliferation index greater than 95%.1 Bcl-2 is not expressed as opposed to double-hit or triple-hit lymphoma. Genetic mutations and aberrancy involving the phosphatidylcholine 3-kinase and cyclin-dependent kinase pathways are also involved.2–5 Rarely patients present with stage I disease and others are considered as high risk if greater than stage I or with elevated LDH or masses greater than 10 cm. © 2020 Elsevier Inc.
Keywords: burkitt lymphoma; aggressive; bl
Journal Title: Clinical Lymphoma, Myeloma and Leukemia
Volume: 20
Issue: Suppl. 1
Meeting Dates: 2020 Sep 9-12
Meeting Location: Houston, TX
ISSN: 2152-2650
Publisher: Elsevier Inc.  
Date Published: 2020-09-01
Start Page: S37
End Page: S38
Language: English
DOI: 10.1016/s2152-2650(20)30455-9
PROVIDER: scopus
PUBMED: 32862862
DOI/URL:
Notes: Due to Covid-19 pandemic the conference was held virtually -- Export Date: 1 September 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ariela Noy
    351 Noy